Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

Study of DU-176b Aged 80 Years or Older

NCT02801669 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of DKB-119 in Patients in Crow's Feet

NCT06021418 ·Status: UNKNOWN ·Phase: NA

A Study in Patients With Mixed Dyslipidemia

NCT06497127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

NCT03950843 ·Status: UNKNOWN ·Phase: PHASE3

Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins

NCT00377806 ·Status: COMPLETED ·Phase: PHASE4

A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis

NCT00851500 ·Status: COMPLETED ·Phase: PHASE2

SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease

NCT02544204 ·Status: UNKNOWN ·Phase: PHASE2

Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation

NCT02944019 ·Status: COMPLETED

Relative Bioavailability of Single Doses of Dabigatran Etexilate When Administered Alone or in Combination With a Single Dose of Ketoconazole or in Combination With q.d. Ketoconazole at Steady State in Healthy Male and Female Volunteers

NCT02170675 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD

NCT04055883 ·Status: COMPLETED ·Phase: PHASE2

Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease

NCT03247972 ·Status: TERMINATED

Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease

NCT05459519 ·Status: UNKNOWN ·Phase: NA

The Changes in Carotid Plaque Neovascularization After Elovocumab Therapy

NCT04423406 ·Status: UNKNOWN

Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease

NCT05762952 ·Status: RECRUITING ·Phase: PHASE1

Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients

NCT02375633 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients

NCT05856487 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of LCQ908 on Cardiovascular Risk

NCT01474434 ·Status: TERMINATED ·Phase: PHASE2

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

NCT04023552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

NCT01647620 ·Status: TERMINATED ·Phase: PHASE1

Lipid Biomarkers for Diabetic Heart Disease

NCT01752842 ·Status: COMPLETED ·Phase: NA

Randomized Phase IIb Trial of DVC1-0101

NCT02276937 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects

NCT02422446 ·Status: TERMINATED ·Phase: PHASE3

Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors

NCT01806077 ·Status: COMPLETED ·Phase: PHASE1

Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)

NCT00384293 ·Status: TERMINATED ·Phase: PHASE3

Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest

NCT03149406 ·Status: UNKNOWN